Hammertoe Market
is presumed to demonstrate 10.8% CAGR during the forecast period (2018-2023) owing to the
increasing incidences of arthritis, asserts Market Research Future (MRFR). The market touched
a valuation of 172.51 USD million in 2018 and is estimated to garner 288.61 USD million by the
end of 2023. Hammertoe is referred to as a feet-related disorder where the feet bends
permanently. Hammertoe occurs due to an imbalance in the muscles and the ligaments which
holds the toe straight. It usually occurs while wearing narrow shoes or small-size shoes. Muscle
or vein damage, osteoarthritis, rheumatoid arthritis, Charcot–Marie–Tooth disease, stroke, and
other feet problems are some of the major reasons causing hammertoe. While in some cases,
hammertoe in an individual may occur since birth, it usually occurs due to wrong selection of
shoes.
Request Sample Copy:
https://www.marketresearchfuture.com/sample_request/4172
With rising incidences of arthritis among the population, the global hammertoe market is
considered to flourish during the assessment period. Arthritis is one of the most common joint
related problems which generally occurs due to increasing age and osteoporosis and is one of
the major reasons for hammertoe. For instance, as per the Centers for Disease Control and
Prevention, on February 2018, around 54.4 million of the total population has been diagnosed
with arthritis, in which 18.1% were men and 23.4% were women. Moreover, with increasing
expenditure on research and development activities in the healthcare industry, the hammertoe
market is likely to boom during the appraisal period. With growing bones related and
hammertoe problems across the world, the need for advanced healthcare services is increasing.
Competitive Dashboard
The prominent players operating the global hammertoe market are Stryker (U.S), Smith &
Nephew (U.K), Zimmer Biomet Holdings (U.S), Extremity Medical LLC (U.S), Nextremity
Solutions Inc. (U.S), Arrowhead Medical Device Technologies LLC (Tennes